Senior Vice President, Worldwide Head of Hematology Oncology

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary

Bristol Myers Squibb (BMS) is seeking a dynamic and visionary leader to serve as the Senior Vice President, Worldwide Head of Hematology Oncology (Heme/Onc). This individual will play a pivotal role in shaping and executing the global medical and strategic direction for our hematology and oncology portfolio, ensuring scientific and commercialization excellence across our key brands and pipeline assets.

This is a critical leadership role for a bold, patient-focused, and results-driven professional who thrives in a high impact, collaborative environment. The SVP will lead a diverse, global team to deliver groundbreaking therapies to patients, influence global healthcare systems, and cement BMS’s position as a leader in the hematology/oncology space.

Key Responsibilities Strategic Leadership

• Develop and execute the global medical strategy for the Heme/Onc portfolio, ensuring alignment with corporate goals and patient impact imperatives.

• Partner with R&D, Commercial, and Market Access teams to shape pipeline and portfolio strategies that maximize value and deliver life-changing therapies to patients.

• Anticipate and respond to dynamic market landscapes, including scientific, regulatory, and competitive challenges, ensuring a leadership position for BMS in the global oncology market. Portfolio Impact and Innovation

• Drive scientific excellence and innovation across the portfolio, integrating clinical, medical, and scientific insights to support launches, life cycle management, and medical differentiation.

• • Champion early differentiation strategies and signal-seeking initiatives to expand the pipeline and identify transformative therapeutic opportunities.

• Oversee the execution of strategic engagement plans with key stakeholders, including thought leaders, advocacy groups, and healthcare systems.

• Ensure appropriate access for patients across US and International markets

Operational Excellence and outcomes

• Lead a high-performing, inclusive, and diverse team of medical and scientific professionals, fostering a culture of accountability, collaboration, and empowerment to achieve exceptional results.

• Champion organizational efficiency and agility by implementing streamlined processes that enable seamless global execution of strategic programs, initiatives, and high-impact launches.

• Leverage advanced digital capabilities and data-driven tools to optimize decision-making, enhance stakeholder engagement, and provide actionable insights that shape medical and business strategies.

• Establish and maintain robust systems to ensure a relentless focus on measurable outcomes across all medical activities, tracking and evaluating performance metrics to drive sustained impact, operational excellence, and continuous improvement.

• Align execution with strategic imperatives, prioritizing initiatives that maximize patient and business impact in hematology and oncology.

External Leadership and Influence

• Serve as the global medical face of BMS Heme/Onc, representing the organization with key external stakeholders, including regulatory agencies, academic and community institutions, medical organization, population decision-makers and patient advocacy groups.

• Lead efforts to strengthen BMS’s reputation as the partner of choice in the oncology space by advancing our commitment to patient-centric care and science-driven solutions.

• Establish strategic partnerships to accelerate access, innovation, and scientific collaboration globally.